(Reuters) -Swiss pharmaceutical giant Novartis has agreed to acquire Anthos Therapeutics, a biopharma firm majority-owned by ...

Novartis has agreed to acquire Anthos Therapeutics, a developer of a new generation of blood thinners it launched five years ...

For more information visit www.novartis.ca. 1 Fabhalta® (iptacopan capsules) Product Monograph. January 6, 2025. 2 Cançado RD, Araújo A da S, Sandes AF, et al. Consensus statement for diagnosis ...

Vincent Gaynor remembers, almost to the minute, when he realized his part in birthing the breakthrough gene therapy Zolgensma ...

For more information visit www.novartis.ca. References _____1 Fabhalta® (iptacopan capsules) Product Monograph. January 6, 2025. 2 Cançado RD, Araújo A da S ...

Eye Health Ingredients Market BURLINGAME, CA, UNITED STATES, February 21, 2025 /EINPresswire / -- The latest study, titled Eye Health Ingredie ...

Trump’s tariffs on products from the EU and TK add to a big trade bill that will hit U.S. states, with Texas and California ...

In this week's InnovationRx newsletter, federal judges halt Trump's cuts to NIH research payments, rural hospitals' ongoing ...

The Super Bowl is always packed with attention-grabbing ads, but Novartis’s cleavage-packed commercial created particularly ...

Swiss pharmaceutical firm Novartis said on Tuesday that it has agreed to buy privately held, clinical-stage US biotech Anthos ...